Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

A man who fainted in the Oval Office last week was a patient of a weight-loss drug company, according to reports.

A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and ...

There’s plenty to like about the lower direct-to-consumer prices the White House negotiated with Eli Lilly and Novo Nordisk. There are also caveats and some unanswered questions.

President Trump hailed his deal with pharma companies on GLP-1 drug pricing. The question is how big of a difference the deal ...

Pharma giants Eli Lily (LLY) and Novo Nordisk (NVO) have signed deals with U.S. President Donald Trump to slash the prices of some of their obesity drugs, including upcoming pills, as per a White ...

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

A medical emergency during a White House event on weight-loss drug price cuts has sparked controversy and speculation about President Trump's response. This article explores the incident's ...

Despite President Trump’s claims, scientists don’t have enough evidence to say acetaminophen use during pregnancy is linked ...

SNL Oval Office cold open recreates the November 6 collapse and turns it into a riff on shutdowns, prices, and elections, ...

The prolonged shutdown has taken a toll on consumer confidence and the overall economy, with consumer sentiment dropping to ...

Pfizer Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma ...